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Background: Elastic fibers enhance the stiffness of fibrotic tissues, but their role in the path-
ophysiology of idiopathic pulmonary fibrosis (IPF) has not been fully examined. The aim of this
study was to determine clinical significance of the amount of elastic fibers in IPF.
Methods: We studied the surgical lung biopsy specimens of 43 patients with IPF. Histological
specimens were stained using the Elastica Van Gieson method and digital images were taken.
The number of pixels containing elastic fibers was divided by the number occupied by fibrotic
tissue, from which the proportion of elastic fibers (elastic fiber score, %) was calculated. The
relationships between the elastic fiber score and clinical, radiological and pathological find-
ings, and prognosis were explored.
Results: The median elastic fiber score was 10.9% (range 5.1e23.3%). Scores were inversely
correlated with % predicted forced vital capacity (r 0.451, p-value 0.003) and positively
correlated with decline in forced vital capacity over 12 months (r 0.475, p-value 0.033).
Furthermore, elastic fiber score correlated with the extent of fibrotic lesions assessed on high
resolution computed tomography as well as the degree of collagen deposition on biopsy spec-
imens. Patients with high elastic fiber scores had significantly worse outcomes than those
with low scores (5-year survival rate was 48.7% and 84.0%, respectively, p-value 0.024),
and elastic fiber score was an independent predictor of poor prognosis (hazard ratio 1.21,
p-value 0.005).3) 435 2263; fax: þ81 (53) 435 2354.
d.ac.jp (N. Enomoto).
3 Elsevier Ltd. All rights reserved.
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Elastic fibers in idiopathic pulmonary fibrosis 1609Conclusion: The amount of elastic fiber in fibrotic tissue is a prognostic indicator in patients
with IPF.
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The prognosis of idiopathic pulmonary fibrosis (IPF) is
extremely poor; there are few effective therapeutic in-
terventions and none that reverse disease progression
[1e3]. IPF is a progressive and life-threatening interstitial
lung disease, however the clinical course is not uniform.
The disease may be rapidly progressive, slowly progressive,
or mixed [2], but the mechanisms that determine the
clinical course are not fully understood. As a result, a great
deal of effort has been focused on exploring the prognostic
indicators of IPF. The histopathologic appearance of IPF is
that of usual interstitial pneumonia (UIP), in which dense
collagen deposition and fibroblastic foci with temporal and
spatial heterogeneity can be seen on hematoxylin-eosin
(HE) stained specimens [1]. Lung fibroblastsdmainly myo-
fibroblastsdproduce extracellular matrix (ECM) rich in
collagen and elastic fibers (EF) that give rise to lung fibrosis
and eventually the typical honeycombing appearance. The
deposition of collagen in the lung interstitium has been
studied in detail [4,5]. Importantly, the prognostic signifi-
cance of the degree of collagen deposition has been
demonstrated in IPF [3], but the relationship between EF
deposition and disease progression has not yet been
studied.
All organs contain fibrous connective tissue, which
comprises collagen, reticular, and elastic fibers. The pro-
portion of collagen and elastic fibers determines an organ’s
physical flexibility and elasticity; the lungs have a high
proportion of EF and the quantity of EF determines their
compliance. In lung fibrosis, the presence and proportion of
EF within fibrotic tissue reduces compliance and makes the
lungs stiff. Collagen fibers and EF accumulate simulta-
neously in the fibrotic lesions of interstitial pneumonias in
humans [6,7] and the synthesis and deposition of elastin
have been noted in bleomycin-induced interstitial pneu-
monia in animals [8]. However, the clinical significance of
the amount of EF in fibrotic lesions in IPF remains unclear.
In this study, to determine the significance of EF in IPF,
we quantified the amount of EF in surgical lung biopsy
specimens of patients with IPF using Elastica Van Gieson
(EVG) staining and examined whether the amount of EF
might influence clinical/radiological/pathological findings
and outcomes.Methods
Study population
Ninety-nine patients with idiopathic interstitial pneumonias
(IIPs) underwent surgical lung biopsy in our hospital be-
tween 1988 and 2007. Of 99 patients with IIPs, diagnoseswere as follows: usual interstitial pneumonia (IPF/UIP) 50
patients, nonspecific interstitial pneumonia (NSIP) 26,
desquamative interstitial pneumonia (DIP) 2, respiratory
bronchiolitis interstitial lung disease (RB-ILD) 4, crypto-
genic organizing pneumonia (COP) 7, acute interstitial
pneumonia (AIP) 1, and unclassifiable 9. The diagnosis of
IPF was based on the consensus criteria of the American
Thoracic Society (ATS), European Respiratory Society (ERS),
Japanese Respiratory Society (JRS), and Latin American
Thoracic Association (ALAT) in 2011 [1]. Patients, who met
the criteria of any connective tissue disorders, were
excluded from this study, even though their histopathologic
pattern was UIP. Histologic features of UIP were based on a
previously published report [1,9]. In addition, none of lung
specimens had “Not UIP pattern” of the IPF consensus
criteria, such as hyaline membranes, granulomas, and so
forth [1]. Forty-three patients with IPF/UIP, for whom
clinical findings and surgical lung specimens were available,
participated in this retrospective study. Patients with acute
exacerbation were excluded from the study. The study
protocol was approved by the Ethical Committee in
Hamamatsu University School of Medicine (approval number
23-107).
Quantification of elastic fibers
Lung specimens were obtained from at least two lobes; all
available specimens were examined. Samples were fixed in
neutral buffered 10% formalin and embedded in paraffin.
Staining was performed on 4 mm sections mounted on glass
slides. Sections were stained by the Elastica Van Gieson
(EVG) method using Weigert’s resorcin-fuchsin and Van
Gieson solution. Images of sections, stained with EVG,
were made using a microscope with a charge coupled de-
vice (CCD) camera (DP21, OLYMPUS; Tokyo, Fig. 1B). Im-
ages of fibrotic lesions at 40 magnification were obtained
from all slides. For each, the area occupied by EF was
quantified using imaging software (Image J: National In-
stitutes of Health, Bethesda, MD, and Photoshop elements:
Adobe, San Jose, CA). Briefly, images were converted to
gray scale, then binarized with two different thresholds so
as to quantify the area of the whole fibrotic lung lesion
(Fig. 1C, blue area) and that of EF (Fig. 1D, red area). The
proportion of EF in the fibrotic interstitial area was
calculated by dividing the number of pixels containing EF
(red area) by that of the whole fibrotic lesion (blue area).
For each patient, the mean proportion of EF in all the
histological images was calculated and expressed as a
percentage, the EF score. Patients were divided into two
groups: those with high elastic fiber proportions (high EF)
and low elastic fiber proportions (low EF) based on the
median value of EF, and survival was compared between
two groups.
Figure 1 Images of sections. Images were made using a microscope with a CCD-camera and image analysis software. Surgical lung
specimens of patient with idiopathic pulmonary fibrosis (IPF) were stained with Hematoxylin-Eosin (HE, A) and Elastica-van Gieson
(EVG, B), and imaged lesions at 40-fold magnification in all specimens were captured. Images were changed into gray scale, then,
these images were binarized to detect the area of fibrotic lung lesion using software (C, blue area). Images were binarized with
another threshold to estimate elastic fibers (D, red area). The concentration of elastic fibers, EF score, in fibrotic area was
calculated by dividing the pixel number of elastic fibers (red area) by that of the target fibrotic lung lesion (blue area). Example of
surgical biopsy images from a participant with an EF score of 20.8%.
1610 N. Enomoto et al.Evaluation of other pathological findings
The investigators examining the histological specimens also
evaluated: fibroblastic foci; collagen deposition; cellularity
and organization. The severity of each of these findings was
scored on a scale from 0 to 3 thus: 0, none; 1, mild; 2,
moderate; 3, severe. The presence of honeycombing,
lymphoid hyperplasia and pleuritis were also recorded
(Supplementary Table 1). These findings were reviewed by
two observers; the agreement rates between observers
were evaluated by weighted-kappa coefficients. The co-
efficients were 0.40e0.46. When the score differed be-
tween observers, a consensus was reached after discussion.Evaluation of high resolution computed
tomography (HRCT) findings
The extent of lung fibrosis wasmeasured using HRCTon slices
taken at the bifurcation of the trachea, the base of the lower
lobes, and a third taken at the midpoint. The extent of
fibrosis in each lobe was scored using following system: 0,
none; 1, 1e10%; 2, 11e25%; 3, 26e50%; 4, 51e75%; and 5,
76e100%. The sum of scores from five lobes (0e25) was used
to express the extent of fibrosis throughout each patient’s
lungs. The severity of ground-glass opacity and consolidation
was scored on a same scale as pathologic evaluation. Finally,
the presence of honeycombing evident on HRCT was alsoevaluated (Supplementary Table 2). These findings were
reviewed by two observers; the agreement rates between
them were evaluated by weighted-kappa coefficients. The
coefficients were between 0.41 and 0.79; when the score
differed between observers, a consensus was reached after
discussion.
Data collection
Clinical data, including sex, age, smoking history, symp-
toms, treatment, and survival were obtained from patient
medical records. Laboratory findings, pulmonary function
tests, and bronchoalveolar lavage (BAL) data at the time of
surgical lung biopsy were also recorded.
Statistical analysis
Statistical analyses were performed using StatView J-4.5
(SAS Institute Inc; Cary, NC, US). Categorical data were
compared using the Chi-square test or Fisher’s exact
probability test for independence, and continuous data
were compared using Student’s T-test. The relationship
between EF score and serial data was analyzed using
Pearson’s correlation coefficient, and that between EF
score and discrete variable data was analyzed using
Spearman’s rank correlation coefficient. The overall sur-
vival of each group was estimated by KaplaneMeier curves.
Elastic fibers in idiopathic pulmonary fibrosis 1611The log-rank test was used to compare survival between
two groups. The effect of the EF score on the risk of death
was modeled using Cox’s proportional hazards regression.
All tests were two-sided and statistical significance was
defined as p < 0.05.
Results
Clinical characteristics and laboratory findings
The clinical characteristics of the participants, the results
of their laboratory and lung function tests and bron-
choalveolar lavage (BAL) are summarized in Table 1. Thirty-
two patients (74.4%) were referred to our hospital because
of incidental findings of interstitial abnormalities on annual
surveillance chest X-rays. The other 11 patients visited our
hospital due to their respiratory symptoms such as dyspnea
and dry cough. The mean values of resting PaO2 and forced
vital capacity (FVC) were relatively preserved (83.2 mmHg
and 87.5%, respectively), suggesting that many patients
presented in the early stages of IPF. Therapeutic in-
terventions were made in 22 participants (51.2%) after
surgical lung biopsy. Five received corticosteroids alone, 10Table 1 Clinical characteristics, laboratory, lung func-
tion, and bronchoalveolar lavage fluid findings.
n Z 43 (mean  SD,
range)
Clinical characteristics
Sex, male/female 38/5
Age at biopsy, yr 61.5  9.1 (44, 81)
Observation period, mo 63.7  49.8 (1, 150)
Smoking history,
current/ex/never
20/19/4
Pack-year of smoking 54.9  46.9 (0, 192)
Symptom onset, mo 26.1  29.7 (1, 131)
Detection by medical
check-up, n (%)
32 (74.4)
Acute exacerbation, n (%) 6 (13.9)
Therapeutic intervention,
n (%)
22 (51.2)
Death, n (%) 20 (46.5)
Laboratory findings
Serum LDH, U/L 240  73 (146, 529)
Serum KL-6, U/ml 1212  882 (354, 3290)
Serum SP-D, ng/ml 243  137 (33, 561)
Physiologic findings
Resting PaO2, mmHg 83.2  11.0 (54, 102)
FVC, % predicted 87.5  21.8 (50, 128)
FEV1, % predicted 82.9  9.2 (56.8, 99.1)
BAL fluid cell analysis
Lymphocytes, % 6.4  8.1 (0.5, 36.1)
Neutrophils, % 0.6  1.0 (0, 4.5)
Eosinophils, % 0.4  0.7 (0, 3.3)
Definition of abbreviations: LDH Z lactate dehydrogenase, KL-
6 Z Krebs von den Lungen-6, SP-D Z surfactant protein D,
FVC Z forced vital capacity, FEV1 Z forced expiratory volume
in 1 s, BAL Z bronchoalveolar lavage.corticosteroids and immunosuppressive agents, two pirfe-
nidone alone, one corticosteroids and pirfenidone, and four
received corticosteroids, immunosuppressive agents, and
pirfenidone. During the observation period (mean 63.7
months), acute exacerbation was diagnosed in 6 patients
(13.9%) after surgical lung biopsy. Twenty patients (46.5%)
died, 13 (65%) of respiratory insufficiency and four (9.3%) of
lung carcinoma.
Quantitative analysis of elastic fibers in fibrotic
lung lesions
Using a CCD-camera and analytic software, abundant
elastic fibers (EF) were found in the fibrotic lung lesions of
surgical lung biopsy specimens, and the amount of EF was
readily evaluated by our quantitative analytic method
(Fig. 1). The proportion of EF in fibrotic area, EF score, was
assessed along the procedure written in the “Materials and
Methods” (Fig. 1). All EF scores are shown in Fig. 2. The
median EF score was 10.9% (5.1e23.3%).
Correlation between EF score and lung function
tests
EF scores were inversely correlated with % predicted forced
vital capacity (%FVC, Fig. 3A) but not % predicted forced
expiratory volume in 1 s (%FEV1) (Fig. 3B) or PaO2 levels
(Fig. 3C). In addition, percent predicted diffusing capacity of
the lung for carbon monoxide (%DLCO) did not significantly
correlate with EF scores (p-value 0.669, r 0.128) (data not
shown). Interestingly, EF scores were inversely correlated
with the change in %FVC measured over 12 months (Fig. 3D).
Relationship between EF score and HRCT findings
HRCT images were available in 28 participants. The lung
fibrosis extent scores positively correlated with EF scoresFigure 2 Total elastic fiber (EF) scores of all patients with
IPF. The proportion of elastic fibers, EF score, was calculated
by dividing the pixel number of elastic fibers by that of the
target fibrotic lung lesion. The horizontal bar represents the
median (n Z 43).
Figure 3 The relationship between elastic fiber (EF) scores and lung function findings. The relationship between EF score and %
forced vital capacity (%FVC) (A), % predicted forced expiratory volume in 1 s (%FEV1) (B), PaO2 at rest (C), and the change in %FVC
over 12 months (D). *p < 0.05.
Figure 4 The relationship between elastic fiber (EF) scores and high resolution computed tomography (HRCT) findings. A: the
extent score of lung fibrosis (0e25). B: the presence of honeycombing. Horizontal bars represent medians. *p < 0.05.
1612 N. Enomoto et al.
Figure 5 The relationship between elastic fiber (EF) scores and pathological findings. A: collagen deposition scores, B: fibro-
blastic focus scores, and C: the presence of microscopic honeycombing. Horizontal bars represent medians. *p < 0.05.
Elastic fibers in idiopathic pulmonary fibrosis 1613(Fig. 4A). No significant difference in EF scores was found
between patients with or without honeycombing on HRCT
(Fig. 4B). There were no significant relationships between
EF scores and ground-glass opacity scores (p-value 0.209, rFigure 6 Survival analysis of all patients with IPF. Patients
were divided into two groups: those with high elastic fiber
proportions (high EF) and low elastic fiber proportions (low EF)
based on the median value of EF (10.9%, Fig. 3). The obser-
vation period was 63.7  49.8 months (mean  SD). Patients
with high EF scores had reduced survival compared with pa-
tients with low EF scores (5-year survival rate was 48.7% and
84.0%, respectively, p Z 0.024, n Z 43).0.125) or consolidation scores (p-value 0.325, r 0.381) on
HRCT.
Correlation between EF score and pathologic
findings
EF scores were positively correlated with collagen deposi-
tion scores (Fig. 5A). There was an apparent, but statisti-
cally insignificant trend for EF scores to correlate with the
fibroblastic focus scores (Fig. 5B). Patients with micro-
scopic honeycombing tended to have higher EF scores than
those without microscopic honeycombing (Fig. 5C). EF
scores had no significant correlation with cellularity within
the interstitium or in air spaces (p-value 0.912, r 0.017
and p-value 0.284, r 0.167, respectively), or fibroblast
proliferation within air spaces (p-value 0.556, r 0.091)
(data not shown).
Correlation between EF score and prognosis of
patients with IPF
Participants were then divided into two groups: high EF
score, 11.0%; and low EF score, 10.9% based on the
median EF score. The KaplaneMeier plot of survival prob-
ability from the time of surgical lung biopsy is shown in
1614 N. Enomoto et al.Fig. 6. Patients with high EF scores had significantly lower
survival than those with low EF scores (5-year survival rates
were 48.7% and 84.0%, respectively, p-value 0.024). Pa-
tients with high EF scores also had more extensive collagen
deposition and microscopic honeycombing significantly
than those with low EF scores (Supplementary Fig. 2A and
E, p-value 0.031 and 0.046, respectively). Although there
were no significant differences, those with high EF scores
tended to have more episodes of acute exacerbation (p-
value 0.094, Supplementary Table 3) and more widespread
fibrosis on HRCT (p-value 0.341, Supplementary Fig. 1A)
than those with low EF scores.
Univariate Cox proportional hazards models were used to
identify factors that predict poor prognosis in IPF (Table 2). EF
score on biopsy specimen was a significant prognostic factor
(Table 2). In addition, resting PaO2, existence of honey-
combing on HRCT, the fibroblastic focus score, and change in
%FVC over 12 months also had significant prognostic value
(Table 2). Multivariate Cox proportional hazards models,
adjusted for age and sex, showed that EF score, resting PaO2,
visible honeycombing on HRCT, and the fibroblastic focus
score continued to have significant influences (Table 3).Table 2 Univariate Cox proportional hazards models of surviva
Variable Hazard rat
Age at biopsy, yr 1.022
Sex, female 0.807
Pack-year of smoking 0.996
Current-smoker 0.690
Ex-smoker 0.444
Symptom onset, mo 1.000
Detection by medical check-up 0.676
Complication of lung carcinoma, Negative 0.651
FVC, % predicted 0.979
FEV1, % predicted 1.006
Resting PaO2, mmHg 0.957
Serum KL-6, U/ml 1.000
Serum SP-D, ng/ml 1.000
Eosinophils in BAL, % 1.081
Neutrophils in BAL, % 0.434
Findings on HRCT
Extent score of fibrotic lung lesion 1.160
GGO score 0.854
Consolidation score 0.316
Existence of honeycombing 6.909
Pathological findings
Organizing pneumonia score 0.536
Cellularity score in interstitium 0.627
Fibroblastic focus score 2.058
Collagen deposition score 1.743
Existence of microscopic honeycombing 1.409
Elastic fiber score, % 1.213
Therapeutic intervention, no treatment 0.425
Change in %FVC, %
6 m 0.976
12 m 0.903
Definition of abbreviations: FVC Z forced vital capacity, FEV1 Z for
tomography, GGO Z ground glass opacity, CI Z confidence interval,Discussion
This study was conducted to assess the quantity of EF in the
lungs of patients with IPF, and to determine its clinical
significance. We found that EF score was inversely corre-
lated with %FVC at the time of surgical biopsy and positively
correlated with decline in %FVC over the next 12 months.
Also, EF score correlated with the extent of lung fibrosis on
HRCT. Patients with a high proportion of EF within fibrotic
areas had significantly worse survival compared with those
who did not. Most importantly, EF score was an indepen-
dent prognostic factor for IPF in multivariate Cox’s pro-
portional hazards models.
Elastic fibers are a major component of the extracellular
matrix, and are abundant in normal dynamic connective
tissues such as arteries, ligaments, and the lungs. Elastic
and collagen fibers are laid down in the new extracellular
matrix generated during fibrotic remodeling, and we found
large quantities of those fibers in lungs affected by IPF.
Although EF is needed to provide physiological elastic recoil
within the lungs, abnormal deposition can adversely alter
respiratory movements [10]. Excess amounts of EF affectl.
io 95% CI p Value
Lower Upper
0.968 1.080 0.431
0.227 2.863 0.739
0.984 1.008 0.522
0.141 3.366 0.646
0.088 2.250 0.326
0.966 1.035 0.996
0.215 2.130 0.504
0.255 1.662 0.369
0.956 1.003 0.084
0.958 1.056 0.813
0.912 0.990 0.036*
0.999 1.001 0.859
0.996 1.004 0.862
0.618 1.915 0.790
0.129 1.465 0.178
0.970 1.386 0.103
0.314 2.327 0.758
0.056 1.793 0.193
1.569 30.42 0.011*
0.226 1.271 0.153
0.257 1.527 0.304
1.078 3.930 0.029*
0.843 3.606 0.134
0.549 3.618 0.476
1.066 1.381 0.003*
0.152 1.188 0.103
0.914 1.043 0.478
0.824 0.990 0.029*
ced expiratory volume in 1 s, HRCT Z high resolution computed
*p < 0.05.
Table 3 Multivariate Cox proportional hazards models of survival adjusted for age and sex.
Variable Hazard ratio 95% CI p Value
Lower Upper
FVC, % predicted 0.981 0.958 1.005 0.124
Resting PaO2, mm Hg 0.954 0.916 0.994 0.025*
Existence of honeycombing
on HRCT
9.013 1.624 50.02 0.012*
Fibroblastic focus score 2.013 1.034 3.918 0.040*
Elastic fiber score, % 1.210 1.060 1.381 0.005*
Definition of abbreviations: FVC Z forced vital capacity, HRCT Z high resolution computed tomography, CI Z confidence interval,
*p < 0.05.
Elastic fibers in idiopathic pulmonary fibrosis 1615“hardness” or “stiffness” of lungs and increase the work of
breathing in the early inspiratory phase due to enhanced
elastic recoil. The role of EF in the pathophysiology of
interstitial pneumonias has not received a great deal of
attention. A recent imaging study found a significant in-
crease in the proportion of EF in the alveolar septum in a
variety of interstitial pneumonias, regardless of histologic
appearance [6]. The authors concluded that “fibroelas-
tosis”, rather than an exclusive process of fibrosis, occurs in
interstitial pneumonias. However, the clinical significance
of EF in IPF has not yet been elucidated. We have shown
that the amount of EF is associated with functional,
radiologic, and pathologic findings, and is an independent
prognostic factor for IPF.
The clinical course of IPF varies widely, and a variety
of factors have been extensively explored as potential
prognostic indicators. Baseline %FVC, decline in %FVC
over 6 or 12 months, and extent of fibrosis on HRCT are
predictive variables of survival in IPF [1]. In our study, EF
scores were inversely correlated with %FVC at surgical
lung biopsy and the change of %FVC in 12 months.
Moreover, EF scores were positively correlated with the
lung fibrosis extent scores on HRCT. These results indi-
cated that the amount of elastic fiber was related to not
only the baseline severity but also disease progression of
IPF. With regard to pathological findings, we and others
have previously demonstrated that the amount of fibro-
blastic foci [11e13] and the extent of collagen deposition
[3] are also a prognostic factor for IPF patients. Our
findings show that the proportion of EF within fibrotic
lesions is a useful prognostic indicator. These data extend
knowledge about prognostic significance of histologic
findings in IPF.
The quantity of EF in tissues is determined by the bal-
ance between production and degradation. In fibrotic
diseases, EF is mainly produced by activated fibroblasts.
EF is degraded by matrix metalloproteinase (MMP, espe-
cially the isoform MMP-9) and elastase produced by mac-
rophages and neutrophils [14]. EF degradation can be seen
in chronic obstructive pulmonary disease (COPD) [15e17],
and smoking directly induces macrophages and neutrophils
to release elastase in the lung. In our study, there was no
relationship between pack-years of smoking or smoking
history (Supplementary Table 3) and the proportion of EF,
suggesting that the increased quantity of EF in the fibrotic
areas may result from enhanced local production ratherthan impaired degradation. Elastin is synthesized by fi-
broblasts and other mesenchymal cells. Its initial form is as
a monomerdtropoelastind that cannot be deposited in
the extracellular matrix before being covalently cross-
linked by lysyl oxidase-like 1 and 2 proteins (LOXL1 and
LOXL2) and fibulin-5. An inhibitory monoclonal antibody
against LOXL2 inhibits covalent cross-linking, which in turn
can ameliorate lung fibrosis in a mouse model [18]. It is not
yet known whether these mechanisms play any role in the
elastin cross-linking required to deposit EF in lungs
affected by IPF.
Our study has a number of limitations. The number of
participants with biopsy-proven IPF is relatively small,
mostly because fewer patients now undergo diagnostic
surgical lung biopsy. Also, the study was conducted retro-
spectively, and a larger, prospectively-enrolled cohort
study would be the ideal study design. Finally, our study
population included patients in the early stages of IPF with
relatively well preserved lung function, as three quarters
were referred to our hospital due to interstitial abnormal-
ities on annual surveillance chest x-rays rather than func-
tionally limiting symptoms.
In conclusion, we found abundant quantities of EF in
fibrotic areas of the lungs of patients with IPF. Quantitative
assessment of EF in IPF provides important prognostic in-
formation: the patients with a high proportion of EF had a
poor prognosis, reduced lung function, and more extensive
and severe histopathologic and radiologic findings. Mecha-
nistically, EF within fibrotic lesions determines the
compliance of lungs affected by IPF, raising the possibility
that preventing the accumulation of EF may represent a
novel therapeutic target in this disease for which there are
limited treatment options.Author contributions
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